Immatics is a biotechnology company focused on transforming cancer treatment through precision targeting of the PRAME antigen, which is present in over 50 types of cancer. We lead the market with a comprehensive clinical pipeline that includes innovative TCR T-cell therapies and TCR bispecifics, setting the standard for effective cancer therapies.
No jobs found. Subscribe below to get notified when we find something for you.
Searching
Companies
Want job alerts that match your preferences?
Set up job preferences →